|
Takeda announces approval of Moderna's COVID-19 vaccine in Japan
|
21 May 2021 |
|
Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan
|
29 October 2020 |
|
Takeda to invest more than 100 million Euros in dengue vaccine manufacturing plant in Germany
|
01 December 2016 |
|
Takeda announces sale of respiratory portfolio to AstraZeneca
|
16 December 2015 |
|
Takeda establishes new trading company and reinforces business structure in China
|
22 January 2013 |
|
Takeda's exclusive distribution of Pfizer products in Japan
|
18 June 2012 |
|
Takeda to Acquire URL Pharma
|
12 April 2012 |
|
Open-source drug research consortium draws a major new champion
|
05 April 2012 |
|
New Structure of Business Operations for a Global Pharmaceutical Company
|
06 November 2011 |
|
Takeda completes acquisition and names new CEO of Nycomed
|
30 September 2011 |
|
Takeda to Acquire Nycomed - Transaction will Transform Takeda's Global Business
|
19 May 2011 |
|
Takeda to Establish Four Sales and Marketing Subsidiaries
|
05 October 2009 |
|
Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filing in Europe
|
11 June 2009 |
|
Takeda to Sponsor Berlin Marathon 2007
|
29 September 2007 |
|
Lundbeck and Takeda form Alliance to Develop and Commercialize a Portfolio of Novel Compounds
|
18 September 2007 |
|
Takeda's Investigational Compound TAK-536 Enters into Phase 2 Clinical Stage in Japan
|
03 September 2007 |